A Clinical study of Aamalakiawaleham and Dadimadighritam in the management of Anaemia(Pandu).
Phase 1
- Conditions
- Health Condition 1: D50-D89- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Registration Number
- CTRI/2020/01/022895
- Lead Sponsor
- CARC Nigdi Pune
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients having lakshanas of Pandu.
Patients having Hb% between 7 to 11%.
Exclusion Criteria
Mrudbhakshanjanya & Garbhini pandu.
Pandu associated with other chronic disprders like liver cirrhosis, ascitis, CCF,alcoholic liver diseases, HIV etc.
Patients with Updrava of Pandu.
Any type of malignant diseases e.g. Leukaemia metastatic cancer etc.
Acute Heamorrhagical and infectious condition.
Patient taking treatment from any other pathy for the same problem.
Known patients of DM.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacy of Aamalakiawaleham and Dadimadighritam in the management of Pandu.Timepoint: 2 Months with Follow Ups after 15 Days.
- Secondary Outcome Measures
Name Time Method To Study The Side Effects of Drug If Any.Timepoint: 2 Months.